Connect with us
Chiesi Global Rare Diseases is a business unit of the Chiesi Pharmaceuticals Group established to offer innovative therapies and solutions to people with rare diseases. Its...
Peaches Biotech is specialized in the creation of medicines based on advanced therapies, especially with cytokines, stem cells, or T-lymphocytes, which will allow patients to take...
With this analysis, they can deduce the aggressiveness of adenocarcinoma and leiomyosarcoma uterine tumors. The starting point was a previous study in which the same tools...
LifeX Ventures already has 12 startups in its portfolio (nine US and three European) and plans to raise this figure to a maximum of 45. For...
The objective of advanced home telecare is to improve the quality of life of the elderly, ensuring intervention when they have a personal, social, or medical...
Biointaxis has received more than €2 million from the Center for Industrial Technological Development (Cdti), a public business entity whose objective is to promote innovation and...
Trea Healthcare Ventures will focus on around twenty-25 companies and will have an investment portfolio that can be common, preferred, Safe (Simple Agreements for Future Equity) shares, as well...
The six listed pharmaceutical companies closed the first quarter with a stock market value of €9.5 billion, compared to €10.6 billion at the close of the...
Vall d'Hebron is one of the main public hospitals in Spain. The center received 1.1 million outpatient visits (115,422 more than in 2020), more than 180,600...
Vytrus Biotech closed 2022 with a capitalization of more than €24 million, an increase of 98% since its debut on BME Growth, the SME stock market,...
 |
|
 |  |
 |
|